Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

17.28USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$17.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
390,461
52-wk High
$20.76
52-wk Low
$6.75

Latest Key Developments (Source: Significant Developments)

Corcept Therapeutics posts Q3 earnings per share $0.11
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corcept Therapeutics Inc :Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update.Q3 GAAP earnings per share $0.11.Q3 revenue $42.8 million versus I/B/E/S view $42 million.Q3 earnings per share view $0.14 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $157 million to $162 million.  Full Article

Corcept Therapeutics reiterates FY 2016 revenue guidance
Tuesday, 1 Mar 2016 

Corcept Therapeutics:Reiterates Fy 2016 revenue guidance of $76-81 million.FY 2015 revenue of $79 million - Thomson Reuters I/B/E/S.  Full Article

Corcept Therapeutics gives FY 2016 revenue guidance
Thursday, 28 Jan 2016 

Corcept Therapeutics:Estimates Fy 2016 revenue will be $76-81 million.  Full Article

BRIEF-Corcept Therapeutics posts Q3 earnings per share $0.11

* Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update